Phase 4Recruiting
Effect of Melatonin, Magnesium, Zinc and Vitamin B12 as Additional Treatment Along with Standard Medicines for High Blood Pressure
Efficacy of a Nutraceutical Combination Melatonin, Magnesium, Zinc, Vitamin B12 as Add On Therapy in Moderately Controlled Essential Hypertension A Randomized, Double Blind, Placebo Controlled Trial - NIL
- Sponsor
- ST Hospitals Private Limited
- Enrollment
- 60 planned
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Interventions
- Nutraceutical Combination Melatonin, Magnesium, Zinc, Vitamin B12
- Registry
- CTRI-2026-09-118443
Full record on the Clinical Trials Registry – IndiaSource: WHO ICTRP, processed October 5, 2026
Primary outcomes
- To assess reduction in systolic and diastolic blood pressure <br/ > Timepoint: Baseline: Before initiation of study intervention <br/ > End of study: 4 weeks after initiation of study intervention <br/ >
History
Started
Last registry update
Registered